Clinical Trial Update: LET Optimized IMPT in Treating Pediatric Patients With Ependymoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from MD Anderson is evaluating LET-optimized intensity-modulated proton therapy (IMPT) for pediatric ependymoma and anaplastic ependymo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Ependymoma
• Ependymoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anaplastic Ependymoma, Ependymoma | Phase 1 | Status: RECRUITING